华恒生物(688639.SH)发行H股备案申请材料获中国证监会接收

Core Viewpoint - The company Huaheng Biological (688639.SH) has submitted an application for issuing H-shares and listing on the Hong Kong Stock Exchange, indicating a strategic move to expand its capital base and enhance market presence [1] Group 1 - The company submitted its application to the Hong Kong Stock Exchange on September 30, 2025 [1] - The application materials for the issuance and listing have been published on the Hong Kong Stock Exchange's website [1] - The company has also submitted the filing application materials to the China Securities Regulatory Commission, which has recently accepted the application [1]